The mortality rates due to endocrine, nutritional, and metabolic diseases vary significantly across countries, with Croatia leading at 201.5 per 100,000 women, showing a 17.74% increase from 2023. Estonia experienced a substantial increase at 20.02%, while Portugal saw a 2.31% decline. The United States showed an 8% increase, whereas Finland experienced a modest 3.06% rise. Some countries like Iceland and Canada experienced decreases, at -1.06% and -1.51%, respectively.
Future trends indicate the need to watch for advancements in healthcare access and dietary changes globally. Emerging markets might experience rising mortality rates due to lifestyle changes, while developed nations could stabilize or reduce rates with effective public health policies.
Top countries in Endocrine, Nutritional and Metabolic Diseases Mortality by Country
| # | 10 Countries | Units (Female Deaths) Per Hundred Thousand Women | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Croatia | 201.5 | 2023 | +12.63% | +17.74% | View data |
| 2 | 2 Mexico | 111.7 | 2023 | +1.18% | +4.18% | View data |
| 3 | 3 South Africa | 69.5 | 2023 | +0.72% | +0.86% | View data |
| 4 | 4 Czech Republic | 64.3 | 2023 | +3.88% | +4.18% | View data |
| 5 | 5 Austria | 55.7 | 2023 | +3.92% | +4.04% | View data |
| 6 | 6 United States | 55.4 | 2023 | +5.93% | +8% | View data |
| 7 | 7 Latvia | 53.4 | 2023 | +1.91% | +6.99% | View data |
| 8 | 8 Portugal | 53.3 | 2023 | -0.56% | -2.31% | View data |
| 9 | 9 Estonia | 52.8 | 2023 | +12.34% | +20.02% | View data |
| 10 | 10 Costa Rica | 51.3 | 2023 | +0.79% | +12.63% | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...
